Skip to content

Clinical trials

Phase 3 Hypersensitivity trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypersensitivity Phase: Phase 3 Country / region: Spain Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20151
20161
20173
20184
20202
20214
20222
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Recruiting3
Terminated3
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Aimmune Therapeutics, Inc.5
Inmunotek S.L.5
Celgene2
Pfizer2
ALK-Abelló A/S1
AstraZeneca1
DBV Technologies1
Ellodi Pharmaceuticals, LP1
Laboratorios Leti, S.L.1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypersensitivity20
Peanut Hypersensitivity6
Asthma5
Immune System Diseases5
Hypersensitivity, Immediate4
Eosinophilia3
Eosinophilic Esophagitis3
Esophageal Diseases3
Esophagitis3
Gastroenteritis3

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.